Bioss Inc is an antibody developer and manufacturer with state-of-the-art technologies. They have developed over 11,000 primary antibodies and more than 130,000 derived products including fluorochrome-conjugated antibodies. In addition to reliable loading control and tag antibodies, the catalog includes over 1000 specific antibodies recognizing proteins with phosphorylation, acetylation, or methylation modifications.